[Pe-055] English Poster Session 055「Neurogenetics, Gene therapy, and iPS cell 3」

[Pe-055-2] Establishment of a leukoencephalopathy iPSC cohort for disease modeling and drug discovery

Takeo Kawano¹, Takayuki Kondo^1,2, Satoshi Morita¹, Mika Suga^1,2, Keiko Imamura¹, Ayako Nagahashi¹, Takako Enami¹, Kayoko Tsukita¹, Takashi Ayaki³, Naohiro Egawa³, Yumi Yamamoto⁴, Kazuhiro Ishii⁵, Masafumi Morimoto⁶, Toshiki Mizuno⁷, Yuishin Izumi⁸, Masafumi Ihara⁴, Hidekazu Tomimoto⁹, Hitoshi Osaka¹⁰, Ryosuke Takahashi³, Haruhisa Inoue^1,2 (1.Center for iPS Cell Research and Application (CiRA), Kyoto University, Japan, 2.iPSC-based Drug Discovery and Development Team, RIKEN BioResource Research Center, Japan, 3.Department of Neurology, Kyoto University Graduate School of Medicine, Japan, 4.National Cerebral and Cardiovascular Center, Japan, 5.Department of Neurology, Division of Clinical Medicine, Faculty of Medicine, University of Tsukuba, Japan, 6.Department of Pediatrics, Kyoto Prefectural University of Medicine, Japan, 7.Department of Neurology, Graduate School of Medical Science, Kyoto Prefectural University of Medicine, Japan, 8.Department of Neurology, Tokushima University Graduate School of Biomedical Sciences, Japan, 9.Department of Neurology, Graduate School of Medicine, Mie University, Japan, 10.Department of Pediatrics, Jichi Medical University, Japan)